Skip to main content

Sign Up For Updates

Important Safety Information
Prescribing Information

ANDEMBRY® (garadacimab-gxii)

Top menu

Sign Up For Updates
Important Safety Information
Prescribing Information
For Healthcare Professionals

Mobile Main Navigation

Why ANDEMBRY
- Efficacy
- How ANDEMBRY Works
Getting Started with Andembry
Taking ANDEMBRY
Safety
Resources

Main navigation

Why ANDEMBRY
- Efficacy
- How ANDEMBRY Works
Getting Started with Andembry
Taking ANDEMBRY
Safety
Resources

Thank You for
Your Feedback

We appreciate you completing the ANDEMBRY survey.

Your responses help us tailor the information we provide.
Thanks again for your time and interest in ANDEMBRY.

Important Safety Information

What are the possible side effects of ANDEMBRY?

The most common side effects of ANDEMBRY include:

Redness, itchiness, and bruising (injection-site reactions)
Stomach (abdominal) pain
Runny or stuffy nose, sneezing, watery eyes (nasopharyngitis)

What is ANDEMBRY?

ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.

It is not known if ANDEMBRY is safe and effective in children under 12 years of age.

What should I tell my healthcare provider before using ANDEMBRY?

Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.

Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.

How should I use ANDEMBRY?

Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.

ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.

Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.

Important Safety Information

What are the possible side effects of ANDEMBRY?

The most common side effects of ANDEMBRY include:

Redness, itchiness, and bruising (injection-site reactions)
Stomach (abdominal) pain
Runny or stuffy nose, sneezing, watery eyes (nasopharyngitis)

What is ANDEMBRY?

ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.

It is not known if ANDEMBRY is safe and effective in children under 12 years of age.

What should I tell my healthcare provider before using ANDEMBRY?

Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.

Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.

How should I use ANDEMBRY?

Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.

ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.

Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.

Footer

Contact Us
Privacy Policy
Cookie Policy
Terms of Use
Site Map
About CSL Behring
Patent Information
Covid-19 Updates

ANDEMBRY is manufactured by CSL Behring GmbH and distributed by CSL Behring LLC.
ANDEMBRY® is a registered trademark of CSL Behring GmbH.
ANDEMBRY Connect^SM is a service mark of CSL Behring LLC.
©2026 CSL Behring LLC. The product information presented on this site is intended for US residents only. USA-AND-0110-JUL26
www.ANDEMBRY.com